Having trouble accessing articles? Reset your cache.

Avastin bevacizumab: Additional Phase III data

Additional data from the open-label, international Phase III ICON7 trial in 1,528 patients with newly diagnosed ovarian cancer showed that Avastin plus carboplatin and paclitaxel chemotherapy

Read the full 264 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE